Gilead Sciences Aktie
WKN: 885823 / ISIN: US3755581036
15.11.2023 12:57:03
|
Gilead's Kite, Arcellx Expand Partnership
(RTTNews) - Kite, a Gilead Company (GILD) Wednesday announced expansion of its partnership with Arcellx, Inc. (ACLX) by investing in Arcellx's ACLX001 ARC-SparX program in multiple myeloma.
Arcellx will receive $200 million equity investment at $61.68 per share, and an upfront payment of $85 million in cash, which is expected to extend the company's cash runway into 2027.
In December 22, the companies have announced collaboration to co-develop and co-commercialize Arcellx's lead late-stage product candidate, CART-ddBCMA, for the treatment of patients with relapsed or refractory multiple myeloma.
The companies have also expanded the scope of the collaboration for Arcellx's CART-ddBCMA to include lymphomas.
The transaction is expected to close around year-end 2023.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Gilead Sciences Inc.mehr Nachrichten
17.10.25 |
Pluszeichen in New York: NASDAQ Composite beendet den Freitagshandel in der Gewinnzone (finanzen.at) | |
17.10.25 |
Gute Stimmung in New York: S&P 500 zum Ende des Freitagshandels mit Gewinnen (finanzen.at) | |
17.10.25 |
Freundlicher Handel in New York: NASDAQ 100 zum Ende des Freitagshandels mit Gewinnen (finanzen.at) | |
17.10.25 |
Börse New York: S&P 500 verbucht Gewinne (finanzen.at) | |
17.10.25 |
NASDAQ 100-Handel aktuell: NASDAQ 100 verbucht Zuschläge (finanzen.at) | |
17.10.25 |
Freitagshandel in New York: So performt der NASDAQ Composite aktuell (finanzen.at) | |
17.10.25 |
Börse New York: NASDAQ Composite am Freitagmittag wenig verändert (finanzen.at) | |
17.10.25 |
NASDAQ 100-Handel aktuell: NASDAQ 100 legt mittags zu (finanzen.at) |
Analysen zu Gilead Sciences Inc.mehr Analysen
Aktien in diesem Artikel
Arcellx Inc Registered Shs | 86,99 | -2,09% |
|
Gilead Sciences Inc. | 105,98 | 4,33% |
|